1 / 9

R&I: MediPoint: Coronary Stents - Global Analysis and Market

The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Detailed report at: http://www.reportsandintelligence.com/medipoint-coronary-stents-global-analysis-and-forecasts-market

ClaraBeaster111
Télécharger la présentation

R&I: MediPoint: Coronary Stents - Global Analysis and Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MediPoint: Coronary Stents - Global Analysis and Market Forecasts Publisher: Global Data No of pages: 436 Publish Date: Nov 2014

  2. Description The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Among the different types of stents, drug-eluting stents (DES) dominate the market and are considered to be the gold standard of treatment for coronary artery disease. The rising prevalence of disease and associated risk factors, especially in the emerging markets, and improved outcomes with stenting are expected to drive the adoption of coronary stents in the future. Emerging technologies such as the new generation of DES and bioabsorbable stents (BAS) represent the future of the coronary stent market. BAS offer several benefits, including no metal left behind, enhanced vessel healing, feasibility of future interventions and potentially reducing the need for prolonged dual antiplatelet therapy.

  3. Description With improvements in the design of BAS, they have the potential to become the standard of treatment for coronary artery disease in the future. This report focuses on the global coronary stents market in the 10 major markets (10MM) (US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil) for treating coronary artery disease. The global bare metal stents (BMS) and DES market is determined for the 10 countries covered in this report and provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players and market analysis of the different stent segments within the market. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different types of coronary stents. Request for discount at: http://www.reportsandintelligence.com/purchase-enquiry/153506

  4. Scope • An overview of percutaneous coronary interventions, which includes clinical outcomes, diagnosis, and treatment using minimally invasive techniques. • Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, and implications for the coronary stents market. • Pipeline analysis: comprehensive list of products across different stages of development that would impact the coronary stents market with emerging trends and designs in development. • Analysis of the current and future market competition in the global coronary stents market. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

  5. Key Questions Answered • What is the current and future coronary stents market outlook in the developed and emerging markets. What trends are affecting the global coronary stents market? • Which are the key, high growth markets that stent manufacturers should expand into. What coronary stent segments are growing the fastest, and what are the top-selling stents in the category? • Bare metal and drug-eluting stents have been on the market for many years; however, unmet needs still exist with respect to late and very late thrombosis and the need for prolonged dual anti-platelet therapy. How will emerging technologies such as DES with biodegradable polymer/polymer-free systems and BAS fulfill these unmet needs? • What clinical factors and technical specifications influence a physician to use one type of coronary stent over another. What is physician perception and market outlook of BAS?

  6. Table Of Content 1 Table of Contents1 Table of Contents 101.1 List of Tables 181.2 List of Figures 262 Introduction 292.1 Catalyst 302.2 Related Reports 313 Industry Overview 323.1 Disease Overview 323.2 Clinical Outcomes 333.2.1 Treatment Guidelines 333.2.2 Treatment Modalities 343.3 Procedure Trends 483.3.1 United States 503.3.2 European Union 513.3.3 Asia-Pacific 533.3.4 Brazil 55

  7. Table Of Content 3.4 Market Access 563.4.1 Regulatory Process 573.4.2 Physician Decision-Making Process 633.4.3 Role of Group Purchasing Organizations 673.4.4 Lack of Clinical Data 703.4.5 Regional-Level Control 723.4.6 Cost Considerations 733.4.7 Reimbursement Trends 783.5 Regulatory Issues/Recalls 893.5.1 Regulatory Issues 893.5.2 Product Recalls 903.6 Mergers and Acquisitions/ Key Partnerships 903.6.1 Medtronic and Covidien 903.6.2 Arterial Remodeling Technologies and Terumo Corporation 913.6.3 MicroPort Scientific Corporation and Cordis Corporation 913.6.4 Alvimedica and CID 923.6.5 ITGI Medical and Vascular Solutions 92

  8. Table Of Content 3.6.6 Terumo Corporation and Onset Medical Corporation 933.6.7 Atrium Medical and Getinge Group 933.6.8 C.R. Bard and ClearStream Technologies 933.6.9 Biosensors International and Devax, CardioMind, and JW Medical Systems 943.6.10 CeloNova Biosciences and NexeonMedSystems 953.6.11 Medtronic and Invatec 953.6.12 Micell Technologies and MaxcorLifescience 963.6.13 Boston Scientific Corporation and Guidant Corporation 963.6.14 Abbott Vascular and Guidant Corporation 963.6.15 Kaneka Corporation and Fujisawa Pharmaceuticals 973.7 Economic Impact of Coronary Artery Disease 973.7.1 United States 983.7.2 European Union 100Get full TOC at: http://www.reportsandintelligence.com/medipoint-coronary-stents-global-analysis-and-forecasts-market/table-of-contents

  9. FOR MORE DETAILS Visit us at : http://www.reportsandintelligence.com/medipoint-coronary-stents-global-analysis-and-forecasts-market Stay With Us: • TELEPHONE: Direct: +1 (617) 674-4143 • Toll Free: +1 (855) 711-1555E-MAIL: sales@reportsandintelligence.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related